glp 1 news Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan Last night on Channel 7

Background GLP-1 agonists continue to strain plan sponsor budgets due to soaring utilization rates

How do you start a GLP-1 weight-loss medication

FDA Sends Warning Letters to Telehealth Companies The FDA has recently issued warnings to 30+ telehealth companies regarding the prescribing and promotion of compounded GLP-1 drugs, including semaglutide

The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel